Revolution Medicines (RVMD) Interest Coverage Ratio (2019 - 2026)
Revolution Medicines (RVMD) posted quarterly Interest Coverage Ratio of 0.38 for Q1 2026, up 73.0% year-over-year from 0.22 in Q1 2025, and down 101.29% quarter-over-quarter from 29.5 in Q4 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Revolution Medicines' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 0.38 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 73.0% year-over-year to 0.38; the TTM figure through Mar 2026 stood at 1.19 (up 74.35% YoY), while the FY2025 annual figure was 1.34, up 46.49% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.38, down from 29.5 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 77.01 in Q4 2024, with the low at 1.41 in Q1 2025.
- The 5-year median for Interest Coverage Ratio is 0.84 (2022), against an average of 8.12.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio tumbled 208.95% in 2022, then soared 7981.03% in 2024.
- Revolution Medicines' Interest Coverage Ratio stood at 44.08 in 2022, then slumped by 102.22% to 0.98 in 2023, then soared by 7981.03% to 77.01 in 2024, then tumbled by 61.69% to 29.5 in 2025, then slumped by 101.29% to 0.38 in 2026.
- Business Quant data shows RVMD's Interest Coverage Ratio at 0.38 in Q1 2026, 29.5 in Q4 2025, and 0.96 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 1,199.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.24 |
| Mar 31, 2026 | -36.50 |
| Dec 31, 2025 | -30.30 |
| Sep 30, 2025 | -27.59 |
| Jun 30, 2025 | -305.32 |
| Dec 31, 2024 | 77.01 |
| Mar 31, 2024 | -50.15 |
| Mar 31, 2021 | -3,116.42 |
| Dec 31, 2020 | -2,434.29 |
| Sep 30, 2020 | -1,620.65 |
| Jun 30, 2020 | -1,472.84 |
| Mar 31, 2020 | -1,003.90 |
| Dec 31, 2019 | -850.61 |
| Sep 30, 2019 | -542.36 |
| Jun 30, 2019 | -377.18 |
| Mar 31, 2019 | -347.87 |